Dr Rewerski is the Executive Director and serves on the board of Diamond Clinic. He is also involved as a Sub-Investigator in trials spanning multiple therapeutic areas. During his tenure at Diamond Clinic, Dr Rewerski has overseen successful expansion into multiple new therapeutic areas, focusing on processes ensuring top quality data acquisition and patient satisfaction. He has also been a member of advisory panels for pharmaceutical companies including Bayer AG and Eli Lilly, advising on issues related to protocol design and patient retention.
Dr Rewerski completed his medical training at University of Kansas Wesley Family Medicine Program in Wichita, Kansas and received his medical degree at the Jagiellonian University Medical College in Krakow, Poland. He has been published in the Journal of Clinical and Experimental Rheumatology and the University of Illinois Journal of Law, Technology, & Policy
Dr Rewerski previously obtained his Juris Doctor and Masters of Business Administration degree at the University of Illinois and his undergraduate degree in Economics from Washington University in St. Louis. He previously held roles at the United Nations/W. T. O. International Trade Center, Clifford Chance, Deloitte, Alstom, and as a partner at Shah Rewerski LLP.